We are monitoring the impact of COVID-19 on Europe Active Implantable Medical Devices Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4852
Share on
Share on

Europe Active Implantable Medical Devices Market Research Report – Segmented By Product & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Growth, Trends, Forecast (2020 to 2025)

Pulished: February, 2020
ID: 4852
Pages: 145

Europe Active Implantable Medical Devices Market Size (2020 to 2025)

The size of the Europe Active Implantable Medical Devices Market is valued at USD 5.13 billion in 2020. This value is expected to reach USD 7.49 billion by 2025 to get a 7.86% CAGR during the forecast period. Europe was the second-largest region following North America in the European active implantable medical devices market during the forecast period. Increase in the elder people population, a frequent rise in cardiovascular and neurological diseases propelling market growth.

Rising funds and investments for more advanced technological products and growing stress of cardiovascular diseases and increasing the regularity of neurological disorders propel market growth. The growing number of accidents and injuries is also significantly contributing to the European market. The ever-increasing number of organ failures and the shortage of dearth of organ donors is estimated to augment this region's market. The rising elder people population is witnessing high and regular osteoarthritis and orthopedic injuries requiring implantable orthopedic devices. This factor is estimated to surge the market's growth rate. 

The High costs related to the implantable medical devices, lack of experienced professionals, and high burden and stress on industries may hinder the market. Inexpedient reimbursement policies may obstruct the market. 

The Europe Active Implantable Medical Devices Market report has been segmented and sub-segmented into the following categories:

  • By Product: Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices).
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe.

Based on the region, Europe held the second-largest share in the regional segment of the market. It can be credited to the growth in the geriatric population, increase in the prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increase in the development of innovative and technologically advanced products, and increase in the healthcare expenditure in the region.

The German market is projected to dominate the European market during the forecast period. The massive availability of advanced technologies, growing expenses in healthcare, increasing income levels of people, and demand for large implants' demand is escalating the market demand in the European region. 

The UK's active implantable medical devices market is witnessed to have robust growth during the forecast period. Increasing demand is mounting because of increasing regular cardiovascular diseases and growing occurrence rates of neurological disorders, fueling the market in the region. Raising funds and investments in developing more advanced technological products, increasing utilization and applications of neurostimulators, and favorable reimbursement for ENT processes among the developed countries is considered to boost the market growth during the period.

France is expected to have a significant growth rate in the market in the upcoming years. 

Some of the top companies leading the Europe Active Implantable Medical Devices Market profiled in the report are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC., Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, and Nurotron Biotechnology Co. Ltd.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Product                                        

                                5.1.1 Introduction                           

                                5.1.2 Implantable Cardioverter Defibrillators                      

                                                5.1.2.1 Transvenous Implantable Cardioverter Defibrillators        

                                                                5.1.2.1.1 Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

                                                                5.1.2.1.2 Dual-Chamber Implantable Cardioverter Defibrillators

                                                                5.1.2.1.3 Single-Chamber Implantable Cardioverter Defibrillators

                                                5.1.2.2 Subcutaneous Implantable Cardioverter Defibrillator       

                                5.1.3 Implantable Cardiac Pacemakers                   

                                5.1.4 Ventricular Assist Devices                 

                                5.1.5 Implantable Heart Monitors/Insertable Loop Recorders                     

                                5.1.6 Neurostimulators                 

                                                5.1.6.1 Spinal Cord Stimulators  

                                                5.1.6.2 Deep Brain Stimulators  

                                                5.1.6.3 Sacral Nerve Stimulators               

                                                5.1.6.4 Vagus Nerve Stimulators               

                                                5.1.6.5 Gastric Electrical Stimulators        

                                5.1.7 Implantable Hearing Devices                           

                                                5.1.7.1 Active Hearing Implants 

                                                5.1.7.2 Passive Hearing Implants              

                                5.1.5  Y-o-Y Growth Analysis, By Product                              

                                5.1.6  Market Attractiveness Analysis, By Product                            

                                5.1.7  Market Share Analysis, By Product                              

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Medtronic plc                                            

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Abbott Laboratories                                               

                8.3 Boston Scientific Corporation                                             

                8.4 BIOTRONIK SE & Co. KG                                        

                8.5 LivaNova PLC.                                            

                8.6 Cochlear Limited                                      

                8.7 MED-EL                                        

                8.8 Sonova Holding AG                                 

                8.9 William Demant Holding A/S                                               

                8.10 Nurotron Biotechnology Co. Ltd.                                    

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the region-wise market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Active Implantable Medical Devices Market, By Product, From 2020 to 2025 (USD Billion)
  2. Europe Implantable Cardioverter Defibrillators Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Cardiac Pacemaker Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Ventricular Assist Device Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Neurostimulator Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Implantable Hearing Devices Market, By Region, From 2020 to 2025 (USD Billion)
  7. U.K. Active Implantable Medical Devices Market, By Product, From 2020 to 2025 (USD Billion)
  8. Germany Active Implantable Medical Devices Market, By Product, From 2020 to 2025 (USD Billion)
  9. France Active Implantable Medical Devices Market, By Product, From 2020 to 2025 (USD Billion)
  10. Italy Active Implantable Medical Devices Market, By Product, From 2020 to 2025 (USD Billion)
  11. Spain Active Implantable Medical Devices Market, By Product, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample